These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10215324)

  • 21. Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy.
    Zhang L; Kong D; Meng H; Han C; Zhu J; Qiao J; He Y; Wang T; Li X; Zhang F; Jin X
    Cell Physiol Biochem; 2016; 40(6):1473-1486. PubMed ID: 27997897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    Placzek WJ; Yanagawa H; Makita Y; Renfrow MB; Julian BA; Rizk DV; Suzuki Y; Novak J; Suzuki H
    PLoS One; 2018; 13(1):e0190967. PubMed ID: 29324897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
    Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN; To WY; Li PK; Leung JC
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study.
    Coppo R; Amore A; Gianoglio B; Porcellini MG; Peruzzi L; Gusmano R; Giani M; Sereni F; Gianviti A; Rizzoni G
    Clin Nephrol; 1995 Jan; 43(1):1-13. PubMed ID: 7697930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding capacity of serum IgA to jacalin in patients with IgA nephropathy using jacalin-coated microplates.
    Tomino Y; Ohmuro H; Takahashi Y; Suzuki Y; Saka S; Tashiro K; Shirato I; Koide H
    Nephron; 1995; 70(3):329-33. PubMed ID: 7477622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgA on the surface of erythrocytes from IgA nephropathy patients.
    Matsuda S; Czerkinsky C; Moldoveanu Z; Mestecky J
    Adv Exp Med Biol; 1987; 216B():1577-81. PubMed ID: 3425448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.
    Hashim OH; Shuib AS; Chua CT
    Immunol Invest; 2001 Feb; 30(1):21-31. PubMed ID: 11419909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic aspects of IgA-fibronectin in serum of patients with IgA nephropathy].
    Sela BA; Schechter P; Eisenstein B
    Harefuah; 1995 Aug; 129(3-4):127-30. PubMed ID: 8543239
    [No Abstract]   [Full Text] [Related]  

  • 31. IgA-fibronectin aggregates in IgA nephropathy.
    Roccatello D; Pellegrino N; Bancale E; Vallero A; Quattrocchio G; Ferro M; Coppo R; Piccoli G
    Nephron; 1994; 68(1):146-7. PubMed ID: 7991031
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells.
    Libetta C; Rampino T; Palumbo G; Esposito C; Dal Canton A
    J Am Soc Nephrol; 1997 Feb; 8(2):208-13. PubMed ID: 9048339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimouse laminin antibodies in IgA nephropathy and various glomerular diseases.
    Shinkai Y; Karai M; Osawa G; Sato M; Koshikawa S
    Nephron; 1990; 56(3):285-96. PubMed ID: 1706484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin-immunoglobulin complexes in the early course of IgA and Henoch-Schönlein nephritis.
    Cederholm B; Linne T; Wieslander J; Bygren P; Heinegård D
    Pediatr Nephrol; 1991 Mar; 5(2):200-4. PubMed ID: 2031835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of jacalin binding to serum IgA in IgA nephropathy.
    Andre PM; Le Pogamp P; Chevet D
    J Clin Lab Anal; 1990; 4(2):115-9. PubMed ID: 2313468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells.
    Zhang JJ; Xu LX; Zhang Y; Zhao MH
    Clin Immunol; 2006 Apr; 119(1):103-9. PubMed ID: 16442846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
    Almogren A; Kerr MA
    Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the NH2-terminal domain of fibronectin with heparin. Role of the omega-loops of the type I modules.
    Kishore R; Samuel M; Khan MY; Hand J; Frenz DA; Newman SA
    J Biol Chem; 1997 Jul; 272(27):17078-85. PubMed ID: 9202024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.